Maria Widmar, MD, MPH, FACS (she/her/hers)

Assistant Attending
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical Center
New York, New York, United States

Disclosure information not submitted.

Presentation(s):

• eP133 - Contemporary Analysis of Major Post-Operative Morbidity in Simultaneous Colorectal and Liver Surgery for Metastatic Colorectal Adenocaricnoma

  Sunday, June 2, 2024
  9:18 AM – 9:23 AM ET, USA

• eP217 - Perineal Wound Closure Following Radical Pelvic Surgery: Assessment of Morbidity Following Primary Closure and Various Types of Tissue Flap Reconstruction

  Sunday, June 2, 2024
  9:24 AM – 9:29 AM ET, USA

• GS2 - Postoperative Outcomes Among Rectal Cancer Patients That Fail Watch and Wait: Does Delaying Total Mesorectal Excision Lead to More Complications?

  Sunday, June 2, 2024
  10:27 AM – 10:30 AM ET, USA

• QS121 - Comparison of Readmission Rates Before and After Implementation of Smartphone-based Symptom Monitoring in Patients Undergoing Elective Colorectal Surgery

  Sunday, June 2, 2024
  10:57 AM – 11:00 AM ET, USA

• SS06 - Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-Wait

  Sunday, June 2, 2024
  11:13 AM – 11:21 AM ET, USA

• eP442 - Tailgut Cysts and Malignant Transformation: Single Institution Experience

  Sunday, June 2, 2024
  1:45 PM – 1:50 PM ET, USA

• eP565 - Timing of Recurrence for Patients Diagnosed with Anal Squamous Cell Carcinoma Who Achieve a Complete Response Following Combined Modality Treatment

  Monday, June 3, 2024
  8:21 AM – 8:26 AM ET, USA

• What Is a Ccr and Is Every Rectal Cancer Patient a Candidate for Watch and Wait?

  Monday, June 3, 2024
  8:07 AM – 8:15 AM ET, USA

• eP665 - Predictors and Survival Analysis of Locally Recurrent Colon Cancer at a Single High-volume Institution

  Monday, June 3, 2024
  2:03 PM – 2:08 PM ET, USA

• LB803 - The Cost Effectiveness of Total Neoadjuvant Therapy with Selective Nonoperative Management: An Analysis Based on the OPRA Trial

  Monday, June 3, 2024
  4:02 PM – 4:08 PM ET, USA

• T103 - Rectal Cancer Watch & Wait Strategy: The U.S. Rectal Cancer Research Group Experience with 545 Patients

  Tuesday, June 4, 2024
  8:25 AM – 8:31 AM ET, USA